| Alternative Names: |
Gadolinium, [6,9-bis[(carboxy-kappaO)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-kappaO)ethyl]-11-(oxo-kappaO)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-kappaN3,kappaN6,kappaN9,kappaO1]-, Gadolinium, [8,11-bis[(carboxy-kappaO)methyl]-14-[2-[(2-methoxyethyl)amino]-2-(oxo-kappaO)ethyl]-6-(oxo-kappaO)-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)-kappaN8,kappaN11,kappaN14,kappaO16]- (9CI), 2-Oxa-5,8,11,14-tetraazahexadecan-16-oic acid, 8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-, gadolinium complex, Gadolinium, [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)]-, [6,9-Bis[(carboxy-kappaO)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-kappaO)ethyl]-11-(oxo-kappaO)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-kappaN3,kappaN6,kappaN9,kappaO1]gadolinium, Gadoversetamide, Gd-DTP-BMEA, MP 1177, OptiMARK, [N,N-Bis[2-[[(Carboxymethyl)[(2-methoxyethyl)carbamoyl]methyl]amino]ethyl]glycinato(3-)]gadolinium |